Clinical Trial Update: The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia

View source ↗

Summary

This clinical trial update notes potential risks of heart failure and pneumonia with pramipexole and other dopamine agonists.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Pneumonia

Drugs mentioned

• Pramipexole (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Heart Failure | Status: COMPLETED